<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>cell potency | Oswestry Keele Orthopaedic Research group - OsKOR</title>
    <link>https://oskor.netlify.app/tag/cell-potency/</link>
      <atom:link href="https://oskor.netlify.app/tag/cell-potency/index.xml" rel="self" type="application/rss+xml" />
    <description>cell potency</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-gb</language><copyright>Â© 2025</copyright><lastBuildDate>Wed, 21 Jun 2017 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://oskor.netlify.app/media/logo_hu0e35ae0aaba2517cccb2b0d7ca3e2f28_296151_300x300_fit_lanczos_3.png</url>
      <title>cell potency</title>
      <link>https://oskor.netlify.app/tag/cell-potency/</link>
    </image>
    
    <item>
      <title>Efficacy and safety of autologous cell therapies for knee cartilage defects (autologous stem cells, chondrocytes or the two): randomized controlled trial design</title>
      <link>https://oskor.netlify.app/publication/efficacy-and-safety-of-autologous-cell-therapies-for-knee-cartilage-defects-autologous-stem-cells-chondrocytes-or-the-two-randomized-controlled-trial-design/</link>
      <pubDate>Wed, 21 Jun 2017 00:00:00 +0000</pubDate>
      <guid>https://oskor.netlify.app/publication/efficacy-and-safety-of-autologous-cell-therapies-for-knee-cartilage-defects-autologous-stem-cells-chondrocytes-or-the-two-randomized-controlled-trial-design/</guid>
      <description>
&lt;script src=&#34;https://oskor.netlify.app/publication/efficacy-and-safety-of-autologous-cell-therapies-for-knee-cartilage-defects-autologous-stem-cells-chondrocytes-or-the-two-randomized-controlled-trial-design/index.en_files/header-attrs/header-attrs.js&#34;&gt;&lt;/script&gt;


</description>
    </item>
    
  </channel>
</rss>
